Maximizing the Clinical Impact of Digital Twins Through Integrated Research Data Management

Ash Bassili
Apr 7
4 min read

We were recently approached by a healthcare organization that is bringing personalized medicine to life through a Digital Twin (DT) platform. This is clearly an increasingly important aspect of the future of patient care-especially with the application of AI. Where a medical record is static, a Digital Twin is a dynamic, virtual representation of a physical system, in this case, a human being. It integrates real-time data, historical records, and predictive models that were generated to simulate how a patient might respond to a specific treatment, procedure, or lifestyle change.

The Healthcare Frontier

In healthcare, Digital Twins attempt to simulate outcomes, predict failures, and personalize treatments. But, there is a big gap between the objectives of a DT model and its utility in a healthcare setting. This chasm requires a robust foundation of data integrity, security, and interoperability between the sources of data (patients and EMR records), and the DT model generation. myLaminin’s Research Data Management (RDM) platform bridges this gap.

myLaminin Accelerates, Secures, and Enhances Digital Twin Initiatives

A Digital Twin is only as good as the data that fuels it and its ability to comply with the regulatory framework that governs the use of that data. myLaminin is uniquely engineered to handle the complex lifecycle of DT data acquisition, predictions generation, and tracking of outcomes against those predictions. This requires an integrated suite of modules designed to simplify and accelerate these data management actions:

1. Ethics and Regulatory Oversight

Like other healthcare services, patients will not have confidence in Digital Twin solutions unless they are anchored in trust and compliance.

Dynamic eConsent & IRB/REB Integration - myLaminin’s data collection (survey) and eConsent capabilities work in tandem with our IRB/REB management module. This ensures that participant participation is transparent and that all protocols adhere to jurisdictional standards, are ethically cleared and tracked in real-time. As DT projects evolve, researchers can manage protocol amendments and re-consenting seamlessly-across multiple site clinical trials if necessary.
21 CFR Part 11 Compliance - In every healthcare setting, data integrity is extremely important and there is little room for error in clinical research-especially when it informs patient medications or procedures. myLaminin’s integrated Clinical Trial Operations and Clinical Trial Management System (CTMS) modules are 21 CFR Part 11 compliant providing the security, role-based access controls, electronic signatures, and rigorous audit trails necessary for FDA-regulated environments.

2. Seamless Interoperability and Rich Data Collection

For a DT to be accurate, it must "speak" the language of modern healthcare while capturing the nuances of the patient experience.

HL7 FHIR & EMR Integration - myLaminin’s HL7 FHIR integration allows for the incorporation of real-time data directly from IoMT (medical devices) and Electronic Medical Records (EMRs), allowing the DT to be informed by a continuous stream of validated clinical data.
Integrated Survey & Data Collection - Beyond clinical records, myLaminin’s Survey module allows for the collection of Patient-Reported Outcome Measures (PROMs). This adds a layer of subjective "real-world" data to the Digital Twin model, capturing how a patient feels, not just what their lab results say.

3. Secure Repository Management and Role-Based Access (RBAC)

Digital Twins contain the most sensitive data imaginable. myLaminin’s Data Repository Management provides a centralized, secure home for these digital entities.

Granular RBAC - myLaminin provides a sophisticated framework that can separate and/or integrate access to the DT Projections (the predictive models) and the Raw Participant Data with powerful reporting capabilities that can deliver real-time dashboards and trend reporting.
Comprehensive Audit Trails - Every interaction, from a data update to a model simulation is logged. Our immutable audit trails provide a forensic-level history of the data lifecycle for each DT projection, which is essential for both regulatory audits and ensuring the scientific integrity of the Twin.

4. Packaging, Publishing, and AI Recalibration

The real value of DTs is the ability of the "Twin" to learn to remain accurate. myLaminin facilitates the long-term utility of DT data:

Metadata & Packaging - myLaminin supports DataCite, DDI, and Dublin Core metadata standards with plans to include MIAME and MINSEQE in the near future. myLaminin enables DT providers to package these DT projections, wrapping them in rich, standardized metadata. This ensures the data is "FAIR" (Findable, Accessible, Interoperable, and Reusable).
Delivering a Feedback Loop - By archiving past projections with actual patient outcomes in our repository, researchers can continuously recalibrate the AI models driving the DT. This simplifies the process of ongoing model validation, moving from a static prototype to a living, evolving clinical tool.

Conclusion: DT and RDM Integration is Inevitable

The potential of Digital Twins in healthcare is enormous, but their success is linked to the quality of the infrastructure supporting them. By consolidating eConsent, CTMS, data collection, and repository management into a single, compliant ecosystem, myLaminin removes the friction of fragmented systems. We provide the essential "nervous system" for these powerful solutions, ensuring they are built on a foundation of integrity, security, and continuous learning.

__________________________________

Ash Bassili (article author) is the CEO of myLaminin, a compliance-first Research Data Management platform for regulated cross-institution research. He holds a BSc Hons Life Sciences from Queen’s University, a MSc in Information Technology from Johns Hopkins University, and a Certificate in Blockchain Technologies from MIT Sloan School of Management.